Novo Nordisk says Wegovy pill shows comparable weight-loss to injectable version

Core Insights - Novo Nordisk's experimental Wegovy pill demonstrated a 16.6% weight loss in a late-stage study, which aligns with previous results from the injectable version of Wegovy [1] Company Summary - The data regarding Wegovy was published in The New England Journal of Medicine, indicating a significant advancement in weight-loss treatment options [1]